公司致力于成为中国较为专业的医药CSO公司,目前总代了大型国有上市公司天津达仁堂部分原研独家产品,并有未来六年长远规划和合同保证,后续合作产品非常丰富,公司自有药品批文亦即将上市,未来公司将向持有药品批文和销售落地两个方向深度发展
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows